Growth (GH) and insulin-like growth factor (IGF-I) are both critically important for growth and differentiation in vertebrates. GH is the principal regulator of IGF-I production and acts primarily by activating IGF-I gene transcription. Characterizing the mechanisms responsible for this transcriptional activation should provide new molecular targets for drug design and ultimately lead to better treatment of metabolic and growth disorders. Our laboratory has identified a chromatin region in the rat IGF-I gene termed HS7 that undergoes GH-regulated structural alteration in parallel with hormone-induced transcriptional regulation. The goals of this project are to characterize the molecular mechanisms that mediate activation of IGF-I gene by GH by evaluating the role of HS7 in transcriptional control. The first set of experiments will test the hypothesis that HS7 mediates GH-induced stimulation of IGF-I gene transcription. Several cell lines known to express IGF-I will be transfected with GH receptor and various reporter genes fused to the IGF-I or heterologous promoters with or without the HS7 site. A parallel set of experiments will characterize the nuclear proteins that bind to the IGF-I at the HS7 site. In vitro gel shift assays and foot printing experiments will be used in conjunction with site-specific mutagenesis to identify the specific nucleotides that are necessary and sufficient for high affinity protein binding. Several experimental approaches will be employed to identify and clone the nuclear proteins that interact with HS7. A series of experiments will test the hypothesis that the cloned proteins are specific mediators of GH-regulated IGF-I gene transcription.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DK009802-03
Application #
6176434
Study Section
Special Emphasis Panel (ZRG2-REB (01))
Program Officer
Hyde, James F
Project Start
2000-09-01
Project End
Budget Start
2000-09-01
Budget End
2001-08-10
Support Year
3
Fiscal Year
2000
Total Cost
$37,243
Indirect Cost
Name
Oregon Health and Science University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Meneilly, Graydon S; McIntosh, Christopher H S; Pederson, Raymond A et al. (2003) Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes. Diabetes Care 26:837-42
Woelfle, Joachim; Billiard, Julia; Rotwein, Peter (2003) Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem 278:22696-702
Meneilly, Graydon S; Greig, Nigel; Tildesley, Hugh et al. (2003) Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 26:2835-41
Billiard, J; Umayahara, Y; Wiren, K et al. (2001) Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts. J Biol Chem 276:15354-61
Billiard, J; Grewal, S S; Lukaesko, L et al. (2001) Hormonal control of insulin-like growth factor I gene transcription in human osteoblasts: dual actions of cAMP-dependent protein kinase on CCAAT/enhancer-binding protein delta. J Biol Chem 276:31238-46